Chemical Biology Platform, The Broad Institute, 7 Cambridge Center, Cambridge, MA 02142, USA.
Mol Biotechnol. 2010 Jun;45(2):180-6. doi: 10.1007/s12033-010-9251-z.
Cell-based assays represent approximately half of all high-throughput screens currently performed. Here, we review in brief the history and status of high-throughput screening (HTS), and summarize some of the challenges and benefits associated with the use of cell-based assays in HTS. Approaches for successful experimental design and execution of cell-based screens are introduced, including strategies for assay development, implementation of primary and secondary screens, and target identification. In doing so, we hope to provide a comprehensive review of the cell-based HTS process and an introduction to the methodologies and techniques used.
基于细胞的测定法大约占目前进行的所有高通量筛选的一半。在这里,我们简要回顾高通量筛选(HTS)的历史和现状,并总结了在 HTS 中使用基于细胞的测定法的一些挑战和优势。介绍了成功进行基于细胞的筛选的实验设计和执行的方法,包括测定法开发策略、初级筛选和次级筛选的实施以及靶标鉴定。通过这样做,我们希望提供一个基于细胞的 HTS 过程的全面综述,以及介绍所使用的方法和技术。